Benzinga's Top Downgrades
JMP Securities downgraded AtriCure (NASDAQ: ATRC) from “outperform” to “market perform.” AtriCure's shares closed at $8.10 yesterday. AtriCure's PEG ratio is -1.40.
Analysts at UBS downgraded Allstate (NYSE: ALL) from “buy” to “neutral.” Allstate's shares closed at $36.53 yesterday. Allstate's trailing-twelve-month profit margin is 6.27%.
RW Baird downgraded Nordstrom (NYSE: JWN) from “outperform” to “neutral.” Nordstrom's shares closed at $53.31 yesterday. Nordstrom's trailing-twelve-month ROA is 9.80%.
CLSA downgraded Becton, Dickinson and Company (NYSE: BDX) from “outperform” to “underperform.” Becton, Dickinson's shares closed at $74.42 yesterday. Becton, Dickinson's trailing-twelve-month ROE is 24.92%.
Latest Ratings for ATRC
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2017 | BTIG Research | Downgrades | Buy | Neutral |
| Aug 2016 | Stifel Nicolaus | Maintains | Buy | |
| Aug 2016 | UBS | Maintains | Sell |
View More Analyst Ratings for ATRC
View the Latest Analyst Ratings
Posted-In: Top DowngradesDowngrades Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
